CHOLESTYRAMINE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for cholestyramine and what is the scope of patent protection?

Cholestyramine is the generic ingredient in eight branded drugs marketed by Parke Davis, Ajanta Pharma Ltd, Alkem Labs Ltd, Ani Pharms, Endo Operations, Epic Pharma Llc, Ivax Sub Teva Pharms, Tagi, Teva, Upsher Smith Labs, Zydus Pharms, Teva Pharms, Chartwell Rx, Bristol Myers, and Apothecon, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for cholestyramine. Fourteen suppliers are listed for this compound.

Sponsor	Phase
Centre Hospitalier Universitaire de Nice	N/A
Loxo Oncology, Inc.	Phase 1
Eli Lilly and Company	Phase 1

Sponsor

Phase

Centre Hospitalier Universitaire de Nice

N/A

Loxo Oncology, Inc.

Phase 1

Eli Lilly and Company

Phase 1

US Patents and Regulatory Information for CHOLESTYRAMINE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ivax Sub Teva Pharms	CHOLESTYRAMINE	cholestyramine	POWDER;ORAL	074771-002	Jul 9, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Tagi	CHOLESTYRAMINE	cholestyramine	POWDER;ORAL	209597-002	Mar 9, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Pharms	CHOLESTYRAMINE LIGHT	cholestyramine	POWDER;ORAL	074555-002	Sep 30, 1998		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chartwell Rx	LOCHOLEST LIGHT	cholestyramine	POWDER;ORAL	074562-001	Aug 15, 1996	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alkem Labs Ltd	CHOLESTYRAMINE LIGHT	cholestyramine	POWDER;ORAL	211799-002	Oct 19, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Parke Davis	CHOLYBAR	cholestyramine	BAR, CHEWABLE;ORAL	071621-001	May 26, 1988	⤷ Sign Up	⤷ Sign Up
Parke Davis	CHOLYBAR	cholestyramine	BAR, CHEWABLE;ORAL	071739-001	May 26, 1988	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

BAR, CHEWABLE;ORAL

May 26, 1988

⤷ Sign Up

BAR, CHEWABLE;ORAL

May 26, 1988

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	0
Tradenames:	8
Applicants:	15
NDAs:	25
Drug Master File Entries:	8
Finished Product Suppliers / Packagers:	14
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	39
Drug Prices:	Drug price trends for CHOLESTYRAMINE
What excipients (inactive ingredients) are in CHOLESTYRAMINE?	CHOLESTYRAMINE excipients list
DailyMed Link:	CHOLESTYRAMINE at DailyMed

Drug Class	Bile Acid Sequestrant
Mechanism of Action	Bile-acid Binding Activity

CHOLESTYRAMINE - Generic Drug Details

What are the generic drug sources for cholestyramine and what is the scope of patent protection?

Summary for CHOLESTYRAMINE

Recent Clinical Trials for CHOLESTYRAMINE

Pharmacology for CHOLESTYRAMINE

US Patents and Regulatory Information for CHOLESTYRAMINE

Expired US Patents for CHOLESTYRAMINE

Make Better Decisions: Try a trial or see plans & pricing